Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)
Clinical trial NCT03477500 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03477500
- Sponsor
- Haukeland University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2026-11-21
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.